The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 3 U.S. Children with COVID-19 Have Rare Inflammatory Syndrome

3 U.S. Children with COVID-19 Have Rare Inflammatory Syndrome

April 29, 2020 • By Julie Steenhuysen

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CHICAGO (Reuters)—Three U.S. children infected with the coronavirus are being treated for a rare inflammatory syndrome that appears similar to one that has raised concerns by doctors in Britain, Italy and Spain, a specialist treating the patients told Reuters.

You Might Also Like
  • U.S. to Tell Doctors to Report Cases of COVID-19 Inflammatory Syndrome in Kids
  • More Evidence Links Pediatric Inflammatory Multisystem Syndrome to SARS-CoV-2
  • Unprecedented Cluster of Hyperinflammatory Shock in Kids in U.K., possibly Linked to COVID-19

All three—who range in age from 6 months to 8 years—have undergone treatment at Columbia University Medical Center, New York, and all had fever and inflammation of the heart and the gut, suggestive of Kawasaki disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Right now, we’re at the very beginning of trying to understand what that represents,” Columbia’s Mark Gorelik, MD, tells Reuters.

Dr. Gorelik, a pediatric rheumatologist and immunologist, says he was called in to consult on the cases to evaluate whether the children have Kawasaki disease, an illness thought to be linked to infection that in severe cases causes inflammation of the arteries of the heart.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Italian and British medical experts are investigating a possible link between the coronavirus pandemic and clusters of severe inflammatory disease among infants arriving in hospitals with high fevers and swollen arteries.

The syndrome has been largely undetected in the United States, according to the American Academy of Pediatrics.

Dr. Gorelik says he believes the cases are likely not Kawasaki disease, but a similar process that shares an underlying mechanism with Kawasaki, which is thought to be triggered by an infectious agent that sparks an immune response.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“This has very similar features,” he says.

The three New York cases follow a report at Stanford University, California, in which a 6-month-old was admitted to the hospital with Kawasaki disease and was later diagnosed with COVID-19.

“When the baby came back positive, it was a bit of a surprise,” says Roshni Mathew, MD, a pediatric infectious disease specialist at Stanford’s Lucile Packard Children’s Hospital.

Dr. Mathew, who wrote up the case in the journal Hospital Pediatrics, says the cause of Kawasaki disease is not known, but several pathogens have been suggested as a possible trigger, including some human coronaviruses.1

Until now, children have largely escaped some of the more serious complications of COVID-19, which has taken its greatest toll on older adults and those with chronic conditions.

Dr. Gorelik says it’s possible that in some children, the disease has two phases—the initial infection and a secondary immune response that kicks in some weeks later.

“It seems a week to two weeks later, you may have the immune system responding in a very disorganized way,” he says.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: coronavirus, COVID-19, heart, Kawasaki disease, Pediatric

You Might Also Like:
  • U.S. to Tell Doctors to Report Cases of COVID-19 Inflammatory Syndrome in Kids
  • More Evidence Links Pediatric Inflammatory Multisystem Syndrome to SARS-CoV-2
  • Unprecedented Cluster of Hyperinflammatory Shock in Kids in U.K., possibly Linked to COVID-19
  • Some Rheumatic Diseases Tied to Higher Risk of Severe COVID-19

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.